A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES.
Sitagliptin Phosphate has been studied across 14 research domains including 🔥 Metabolic, 🧬 Hormones, 🔬 Inflammation, 🔬 Oncology, 🧘 Stress & Anxiety. The primary research focus is 🔥 Metabolic with 44% of studies addressing this area.
The following compounds share molecular targets with Sitagliptin Phosphate, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Sitagliptin Phosphate is generated deterministically from 85 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.